Learn about new research on remibrutinib for chronic hives treatment. We break down the REMIX trial results & what this BTK inhibitor means for CSU patients.
An interview with Cherie Zachary, President of the American College of Allergy, Asthma & Immunology, on diversity, training pathways, and the allergist shortage.
Learn how the Pediatric Asthma Impairment and Risk Questionnaire (Peds-AIRQ), a validated tool, was designed to better identify uncontrolled asthma in children ages 5 to 11.
Learn how omalizumab raised allergic reaction thresholds in the OUtMATCH trial for multiple food allergies. It’s not a cure, but it may offer protection.
Learn how doctors diagnose and treat indolent systemic mastocytosis (ISM) with KIT D816V tests, biopsies & targeted therapies like avapritinib to manage symptoms.
Learn about diagnosing and treating mast cell activation syndrome (MCAS) from serum tryptase testing to treatment with antihistamines, cromolyn and omalizumab.
Learn how parents and guardians can prepare for Asthma Peak Week, manage fall triggers, and keep kids safe with action plans, routines, and updated medicines.
Support for food allergy parents! Therapist Tamara Hubbard shares tools to manage anxiety and why mental health matters at every stage of the allergy journey.
Learn how chronic hives (CSU) may increase risk of death. We review findings from a real-world study on CSU, suicide, and the impact of proper treatment.